-
I-Tofacitnib Citrate
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP I-Tofacitnib Citrate Irheumatoid Arthritis Endlwini -
I-Sugammadex yeSodium
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP I-Sugammadex yeSodium I-Neuromuscular blockade Endlwini -
Sacubitril Hemicalcium
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Sacubitril Hemicalcium Endlwini -
Sofosbuvir
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Sofosbuvir HCV Endlwini 32048 √ -
Ribociclib 1374639-75-4
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Ribociclib 1374639-75-4 HR-positive, HER2-negative Andvance ormetastaticbreast Cancers Novartis
AmachizaNgoJuni. 27, 2028 -
Rivaroxaban
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Rivaroxaban I-Anticoagulant Endlwini TDP -
Rosuvastatin Calcium
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Rosuvastatin Calcium I-Hypercholesterolemia Endlwini/CEP 20705 √ CEP2015-240 -
Pitavastatin Calcium
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Pitavastatin Calcium I-Hypercholesterolemia Endlwini -
Pregabalin
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Pregabalin Ukuxhuzula/Neuralgia Endlwini/EP 22223 √ CEP2016-141 -
I-Obeticholic Acid
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP I-Obeticholic Acid Icholangitis yebiliary Endlwini -
Niraparib 1038915-60-4
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Niraparib 1038915-60-4 Ovarian/Fallopian,ityhubhu/primary peritoneal umhlaza Tesaro NgoJanuwari 8, 2028 -
Ledipasvir Actone /PVP
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Ledipasvir Actone /PVP HCV Endlwini √